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ABSTRACT 46 
Background: Recent analyses have shown an emerging positive association 47 
between sex work and HIV incidence among people who inject drugs (PWIDs) in the 48 
SurvUDI network. 49 
Methods: Participants who had injected in the past 6 months were recruited across 50 
the Province of Quebec and in the city of Ottawa, mainly in harm reduction 51 
programs. They completed a questionnaire and provided gingival exudate for HIV 52 
antibody testing. The associations with HIV seroconversion were tested with a Cox 53 
proportional hazard model using time-dependent covariables including the main 54 
variable of interest, sexual activity (sex work; no sex work; sexually inactive). The 55 
final model included significant variables and confounders of the associations with 56 
sexual activity. 57 
Results: Seventy-two HIV seroconversions were observed during 5 239.2 person-58 
years of follow-up (Incidence rates: total=1.4/100 person-years (py), [95%CI: 1.1-59 
1.7]; sex work=2.5/100 py [1.5-3.6]; no sex work=0.8/100 py [0.5-1.2]; sexually 60 
inactive=1.8/100 py [1.1-2.5]). In the final multivariate model, HIV incidence was 61 
significantly associated with sexual activity (sex work: adjusted hazard 62 
ratio (AHR)=2.19 [1.13-4.25],; sexually inactive: AHR=1.62 [0.92-2.88]), and injection 63 
with a needle/syringe used by someone else (AHR=2.84, [1.73-4.66]). 64 
Conclusions: Sex work is independently associated with HIV incidence among 65 
PWIDs. At the other end of the spectrum of sexual activity, sexually inactive PWIDs 66 
have a higher HIV incidence rate, likely due to more profound dependence leading to 67 
increased vulnerabilities, which may include mental illness, poverty and social 68 
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exclusion. Further studies are needed to understand whether the association 69 
between sex work and HIV is related to sexual transmission or other vulnerability 70 
factors.  71 
Keywords : people who inject drugs, HIV incidence, sex work, sexual activity, 72 
injection behaviours  73 
Word count (abstract): 250 74 
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 76 
INTRODUCTION 77 
The Joint United Nations Programme on HIV/AIDS and World Health Organization 78 
(UNAIDS/WHO) working group on global HIV/AIDS and STI surveillance provide 79 
recent updated guidelines for HIV surveillance activities in several epidemiological 80 
contexts 1. In concentrated HIV epidemics, it is recommended to carry out regular 81 
biobehavioural surveys in key populations at higher risk for HIV infection in order to 82 
understand the local HIV epidemic and how it is changing, as well as to identify 83 
opportunities to control the epidemic. These key populations include people who 84 
inject drugs (PWIDs), men who have sex with men (MSM) and commercial sex 85 
workers as well as their clients, because behaviours that increase the HIV risk are 86 
frequent among these populations, i.e. unprotected sex with multiple partners, 87 
injection drug use (needle/syringe-sharing) and unprotected anal sex 1.  88 
People who inject drugs are considered at increased risk for HIV infection mainly 89 
because of sharing contaminated syringes and other injection paraphernalia. Sexual 90 
transmission is possible, but its extent is generally difficult to estimate 2. It has been 91 
suggested that in PWIDs, sexual risks are present but may be masked or 92 
overshadowed by parenteral risks 3. This would be rather likely considering the much 93 
higher risk of HIV transmission of needle/syringe-sharing (0.7% per exposure) 94 
compared to oral (maximum of 0.06% per exposure) or vaginal sex (maximum of 95 
0.15% per exposure), with the exception of anal sex (maximum of 3% per 96 
exposure)4-6. Thus, sexual transmission is more likely to occur in specific situations 97 
such as in the context of commercial sex trade or male homosexual intercourse i.e. 98 
high number of sex partners or frequent anal sex. This in turn may lead to bridging of 99 
HIV and other sexually transmitted and blood-borne infection epidemics between 100 
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PWIDs, who cumulate risks, and individuals who do not, as for example, persons in 101 
the general population 7,8.  102 
Important sex differences exist for sex work and should be taken into account 9-11. 103 
For example, sex work is frequent in PWIDs, but generally much more frequent in 104 
female than in male PWIDs 11. It occurs generally in the context of heterosexual sex 105 
for women (i.e. very low HIV prevalence in clients in most developed countries) and 106 
women are particularly vulnerable to sexual violence and abuse including negotiation 107 
of condom use 10. On the other hand, sex work in men takes place generally in the 108 
context of sex with other men (i.e. very high HIV prevalence in clients in most 109 
developed countries) 12.  110 
The SurvUDI network is a biobehavioural survey among PWIDs of Central Eastern 111 
Canada, ongoing since 1995. Recent analyses of SurvUDI data have shown an 112 
emerging positive association between sex work and HIV incidence among PWIDs 113 
13. In this previous analysis, a time period interaction variable was included (1995-114 
2002 vs. 2003-2009) in a multivariate model and the association of sex work with 115 
HIV incidence was significant for 2003-2009 but not for 1995-2002. Considering that 116 
the questionnaire for the period 2004-2014 includes much more variables than for 117 
the period 1995-2002, repeating this analysis for 2004-2014 has allowed a better 118 
characterization of participants according to the main variable of interest. The 119 
hypothesis was that the association with sex work would be detected for the period 120 
2004-2014. The objectives of the present study were to examine the association 121 
between sex work and HIV seroconversion among PWIDs in the SurvUDI network 122 
between 2004 and 2014 and to compare participants engaging in sex work with 123 
other participants with respect to HIV risks. 124 
125 
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METHODS 126 
Study design and subjects. The complete methodology of the SurvUDI study has 127 
been described elsewhere 14. Briefly, the SurvUDI network is an ongoing 128 
biobehavioural survey for HIV, HCV and associated risk behaviours among PWIDs in 129 
Eastern Central Canada. The network was implemented in 1995 and targets hard-to-130 
reach, mostly out-of-treatment PWIDs. Eligibility criteria include being aged 14 and 131 
older, injecting at least once within the past 6 months, speaking French or English 132 
and being able to provide informed consent. Participants are recruited in urban 133 
areas, including Montréal and neighbouring South Shore, Québec City, the Hull-134 
Ottawa region, and five semi-urban areas of the province of Québec. Overall, since 135 
2004, 94.6% of participants were recruited in harm reduction programs. Others were 136 
recruited in drop-in centres, detention centres, detoxification clinics, and 137 
rehabilitation programmes. Participation includes an interviewer-administered 138 
questionnaire and collection of gingival exudate using the Orasure device 139 
(Bethlehem, Pennsylvania, US) for HIV and HCV antibody testing. The study design 140 
is an open cohort of services where participants who attend harm reduction 141 
programs more than once at times of study enrollment are followed longitudinally. 142 
The present sample includes participants recruited from March 2004 to March 31 143 
2014 who were initially HIV seronegative and with at least one follow-up visit. 144 
Participants are identified using an encrypted code based on their initials, birth date 145 
and sex, and they are given a stipend ranging from CAN$5.00 to $10.00 at the end 146 
of each study visit. All procedures have been approved by the ethics committee of 147 
the Centre de recherche du CHU de Québec.  148 
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Study variables. The dependent variable was HIV incidence. HIV infection was set 149 
at the midpoint between the last HIV negative follow-up visit and the visit when the 150 
HIV positive result was first detected. Potential confounders were identified based on 151 
a literature review and on previous analyses in this cohort. Covariates considered in 152 
the multivariate analyses as potential confounders included age (˂25; ≥25 153 
years)13,15,16, sex 13,15,16, the region where the interview took place (urban or semi-154 
urban/rural) 13, high school completion 17, homelessness 18,19, recent incarceration 155 
15,19, injected and non injected drug use 13,20, cocaine as the most often injected drug 156 
13, injection with strangers (unknown people) 14,18, injection with needles/syringes 157 
used by someone else 13,17, daily injection 13,21, the number of sexual partners 17, 158 
consistent condom use for vaginal and anal sex 22, always injecting alone and 159 
injecting in public places (previous analyses, unpublished data). Sexual activity, the 160 
main exposure of interest, was categorized as a three-level variable, namely, being 161 
sexually active without engaging in sex work (no sex work, NSW), being sexually 162 
active and engaging into sex work (sex work, SW) or being sexually inactive. Sex 163 
work was defined as having client sex partners in the past six months, i.e. partners 164 
giving money, drugs, goods or other things in exchange for sex. The choice for the 165 
reference category (no sex work) was based on the hypothesis that this group would 166 
show the lowest risk compared to the other two groups. This assumption was based 167 
on previous analyses in our population showing that sexual inactivity in male IDUs 168 
was associated with a higher HIV prevalence 14. In the descriptive analyses of 169 
participants according to sexual activity, several variables considered relevant were 170 
presented even if not retained as confounders in the multivariate analysis. Sexual 171 
orientation was added to the questionnaire in February 2011. Questions on 172 
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behaviours referred to the 6 months prior to the interview, except for daily injection 173 
which refers to the last month. 174 
Laboratory procedures. Collected oral fluid samples were kept at 4°C and shipped 175 
within 2 weeks to the Laboratoire de santé publique du Québec (LSPQ; Institut 176 
national de santé publique du Québec), where they were centrifuged upon reception. 177 
The extracted liquid was kept at -20°C for a maximum of 6 weeks until analysis. The 178 
presence of HIV antibodies was assessed by enzyme immunoassay (EIA) using 179 
HIV-1 Vironostika Microelisa System (bioMérieux, Durham, North Carolina, USA) 180 
from 2004 to 2009 and GS HIV-1/HIV-2 PLUS O EIA (Bio-Rad Laboratories 181 
(Canada) Ltd., Montréal, Qc, Canada) thereafter. The presence of HCV antibodies 182 
was assessed using ORTHO® HCV 3.0 ELISA Test System (Bio-Rad Laboratories 183 
(Canada) Ltd., Montréal, Qc, Canada) according to a modified method developed by 184 
Judd et al. 23. Samples were considered negative if results were less than 75% of the 185 
cut-off value. Sample results that were greater than 75% of the cut-off value were 186 
retested in duplicate. A sample was deemed positive if at least two out of three 187 
results were greater than the cutoff value. 188 
Statistical analyses. HIV seronegative participants at baseline who had at least one 189 
follow-up visit for the period from 2004 to 2014 were considered when assessing HIV 190 
incidence rates. Baseline characteristics and behaviours are those reported at the 191 
second visit, i.e. exposure during the first time interval in the Cox proportional hazard 192 
model. Using the Kaplan-Meier method, we estimated the cumulative probability of 193 
seroconversion during follow-up. The cumulative HIV incidence rates were plotted 194 
and compared for sexual activity reported at baseline using the log-rank test. 195 
Bivariate and multivariate Cox proportional hazard regression analyses were carried 196 
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out to evaluate the association between HIV incidence and sexual activity. 197 
Behavioural variables and age were treated as time-dependent variables. The 198 
exposure used for a given time interval corresponds to the exposure measured at 199 
the visit at the end of this interval, i.e. exposure reported for the preceding 6 months. 200 
The final model included significant (p<0.05) variables and confounders i.e. variables 201 
changing other AHR by 10% or more when removed of the complete model. Effect 202 
modification by sex was also tested for the association between sexual activity and 203 
HIV incidence, and was considered statistically significant at a p value of 0.15 or less 204 
(Wald chi-squared test). To compare risk profiles between participants engaged in 205 
sex work and other participants, cross-sectional sex-stratified descriptive analyses 206 
were performed using the last visit for non-seroconverters and the visit when HIV 207 
infection was first detected for seroconverters. Cross-sectional comparisons were 208 
performed using Pearson’s chi-squared tests or ANOVA. All analyses were carried 209 
out using the SAS statistical suite software version 9.4 (SAS Institute Inc., Cary, 210 
North Carolina, USA). 211 
212 
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 213 
RESULTS 214 
Table 1 shows baseline characteristics of participants. The sample included 1 528 215 
participants cumulating 5 239.2 person-years of follow-up, with a majority of men and 216 
of subjects from urban sites. Only a small proportion of PWIDs were less than 25 217 
years old. Homelessness as well as cocaine as the most often injected drug were 218 
frequently reported. Sex work was more frequently observed in women whereas 219 
sexual inactivity was more frequent in men. 220 
Figure 1 shows cumulative hazard of HIV seroconversion and HIV incidence 221 
according to baseline sexual activity for the ten-year period (2004-2014). Occurrence 222 
of seroconversions was proportionally distributed throughout the follow-up period in 223 
all groups. A statistically significant difference was observed between groups, with 224 
the highest cumulative hazard observed in participants who reported sex work 225 
(p<0.0001). The highest HIV incidence rate was observed in participants who 226 
reported sex work (more than three-fold higher compared to sexually active 227 
participants who did not report sex work), followed by HIV incidence rate in sexually 228 
inactive individuals.  229 
In the final multivariate model (Table 2), the association of HIV incidence with sex 230 
work is the second strongest with an adjusted incidence rate ratio of 2.19 [1.13-4.25]. 231 
The strongest association was observed for injection with a needle/syringe used by 232 
someone else (AHR=2.84, [1.73-4.66]). Effect modification analyses showed that the 233 
association between HIV incidence and sexual activity did not vary significantly 234 
according to sex (p-value for effect modification=0.5729). Sex-stratified rate ratios 235 
are presented in table 2. 236 
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Tables 3 and 4 show cross-sectional, sex-stratified analyses of injection and sex 237 
behaviours according to sexual activity. Male SW (Table 3) were significantly 238 
younger and more likely to be homeless and to report a history of incarceration in the 239 
past 6 months compared to other groups. Male SW were also significantly more 240 
likely to use heroin by injection, to report cocaine as the most often injected drug and 241 
to use non-injected crack/freebase, amphetamines and ecstasy. Male SW were 242 
significantly more likely to inject with strangers and to inject with needles/syringes 243 
used by someone else obtained mainly from strangers compared to male NSW. A 244 
large proportion of male SW had sex with at least 6 male sex partners in the past 6 245 
months (41.2%) and reported at least one female sex partner (58.8%). Among male 246 
SW who had multiple male sex partners, 72% reported heterosexual or bisexual 247 
orientation (data not shown). The proportion of men who reported inconsistent 248 
condom use for vaginal or anal sex is high (sex work=42.6%, no sex work=62.7%). 249 
Sexually inactive men were significantly more likely to report daily injection and to 250 
always inject alone compared to other groups. Male SW and sexually inactive men 251 
were more likely to report injection with needles/syringes used by someone else 252 
obtained mainly from strangers compared to male NSW. HCV prevalence (positivity 253 
for HCV antibodies) was significantly higher in male SW compared to other groups 254 
(intermediate in sexually inactive men). 255 
Female SW (Table 4) were more likely to be homeless and to report a history of 256 
incarceration in the past 6 months compared to other groups. They were also 257 
significantly more likely to use injected cocaine, to report cocaine as their most often 258 
injected drug and to use non-injected crack/freebase and ecstasy. Female SW were 259 
more likely to report injection with strangers and injection with a needle/syringe used 260 
by someone else obtained mainly from strangers. The majority of women were 261 
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sexually active. Among female NSW, 25.3% reported at least two male sex partners 262 
in the past six months. Approximately half of female SW had sex with at least 21 263 
male partners in the past six months (48.1%). A high proportion of women reported 264 
inconsistent condom use for vaginal or anal sex (sex work=60.9%, no sex 265 
work=84.1%). Sexually inactive women were significantly more likely to always inject 266 
alone. HCV prevalence (positivity for HCV antibodies) was significantly higher in 267 
female SW compared to the other groups. 268 
269 
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 270 
DISCUSSION 271 
The objectives of the present study were 1) to characterize the association between 272 
sex work (i.e reporting client sex partners) and HIV seroconversion among PWIDs in 273 
the SurvUDI network between 2004 and 2014 and 2) to describe the characteristics 274 
and risk profile of participants who reported sex work in the past 6 months. The 275 
highest HIV incidence rate was observed in participants who reported sex work. In 276 
the multivariate analysis, sex work and injection with a needle used by someone else 277 
were significantly and independently associated with HIV incidence. Both male and 278 
female PWIDs who reported sex work were more frequently in situation of 279 
homelessness and reported more unsafe injecting as well as sexual behaviours. 280 
In the present study, the association between HIV incidence and sexual activity did 281 
not show significant effect modification by sex. Although the direction of the 282 
association is the same for men and women, the association observed in men is not 283 
significant and is weaker than in women. This is not surprising given the small 284 
number of men reporting client sex partners. Thus, it is not clear whether the 285 
absence of a significant modifying effect by sex, as well as the absence of a 286 
significant association among men in the sex-specific analyses, are due to a lack of 287 
power (inability to detect an existing effect modification that could show an 288 
association among women only) or to the absence of modifying effect. 289 
Recently, Kerr et al. 15 also observed a significant association between sex work and 290 
HIV incidence in Vancouver PWIDs (men and women combined), but it did not 291 
remain significant in multivariate analysis. A methodological issue that may explain 292 
differences with the present study is the definition of the reference category for the 293 
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sex work variable. Kerr et al. 15 defined sex work as a dichotomous variable where 294 
«no sex work» presumably included sexually inactive individuals. As observed in the 295 
present study, sexually inactive PWIDs may differ from other participants in their 296 
characteristics as well as their drug use risk patterns. In the present study, compared 297 
to sexually active male who did not report sex work, sexually inactive male were 298 
significantly more likely to report daily injection and injection with needles/syringes 299 
used by someone else obtained mainly from strangers. Sexually inactive participants 300 
may have a more profound dependence associated to increased vulnerabilities, 301 
which may include mental illness, poverty and social exclusion. This could have 302 
confounded the association observed in the above-mentioned study. Several other 303 
studies have examined the link between sex work or sexual risk profile and HIV 304 
transmission in PWIDs of developed countries 16,17,24-29. Most of these studies 305 
reported very similar findings i.e associations with homelessness, incarceration, 306 
cocaine injection and crack use. 307 
Unprotected sex with multiple partners, including unprotected anal sex 30, are 308 
common among the participants of our study. It is difficult to estimate the relative 309 
contribution of unsafe injection and sexual behaviours to the transmission of HIV. 310 
Vickerman et al. 2 have recently proposed a deterministic mathematical model to 311 
estimate the proportion of HIV infections due to sexual transmission in PWIDs 312 
populations. In this model, the HCV prevalence in HIV-infected PWIDs and the 313 
HIV/HCV prevalence ratio are used as markers of sexual transmission.  314 
Several authors have suggested that in PWIDs, sexual risks are present but may be 315 
masked by parenteral risks 3. This may be an explanation why sex work was not 316 
significantly associated with HIV incidence in PWIDs of the SurvUDI network for the 317 
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period 1995-2002 while a positive association emerged afterward 13. Similar findings 318 
were obtained in at least another recent study performed in MSM-PWIDs in San 319 
Francisco 17. In that study, it was suggested that an independent association with 320 
sex work had emerged as a result of an “unmasking” effect, with the prevalence of 321 
needle-sharing declining. This may also be a plausible hypothesis in the present 322 
situation as needle/syringe-sharing in the SurvUDI network significantly decreased 323 
from 1995 to 2014 (data not shown), with large-scale implementation of harm 324 
reduction programs on the whole territory during that period. 325 
In some studies, authors suggested that the association frequently observed 326 
between HIV transmission and crack use may be explained by higher-risk sexual 327 
behaviours in crack users 28,31. This is consistent with the present data where 328 
participants of both sexes who reported sex work were also significantly more likely 329 
to use non injected crack. Interestingly, men who reported sex work were 330 
significantly more likely to report non injected use of amphetamines (similar 331 
observation in women, but not significant) and women who reported sex work were 332 
more likely to use ecstasy. Regardless of whether they reported sex work or not, 333 
sexually active men also reported frequent use of ecstasy. Men who reported sex 334 
work were slightly more likely to report methamphetamine use, but this was not 335 
significant. The complex relationships between drug use and sexual behaviours have 336 
been discussed previously 32. Amphetamine-like drugs, including ecstasy, are known 337 
to be typically used during sexual activities and to be associated with unsafe sexual 338 
activities 32.  339 
The present study may provide several indications to target local public health 340 
interventions. First, most participants who reported sex work are women, more likely 341 
Blouin et al. 2016, Page 16 
 
homeless and reporting frequent unsafe injecting as well as sexual behaviours. 342 
Several authors 9,33 have suggested that public health interventions should be 343 
developed to reduce vulnerabilities among female PWIDs who engage in sex work. 344 
A multilevel, combined approach has been proposed 9, which includes individual and 345 
social harm reduction initiatives, biomedical, as well as structural interventions i.e 346 
addressing homelessness, mental health and poverty issues as well as supporting 347 
legal reform for sex workers to reduce the risk of bloodborne infections, violence and 348 
homicide death 29. Some authors also reported that HIV prevention programs may be 349 
inadequate for MSM/PWIDs 26,27. In the present study, men who reported client sex 350 
partners had multiple male sex partners, but most of them said that their sexual 351 
orientation was heterosexual or bisexual. Consequently, these men are very unlikely 352 
to be reached by interventions targeting MSM whereas interventions targeting 353 
PWIDs may not be adapted to their high risk sexual exposure 26,27. Despite the fact 354 
that PWIDs/MSM/sex workers represent a very small population, targeting 355 
interventions to this population should be a priority considering their potential for a 356 
high level of effectiveness and the possibility of bridging HIV and HCV epidemics 357 
between PWIDs and MSM, as well as between male PWIDs reporting sex work and 358 
their female sex partners 34,35. 359 
The data obtained through the SurvUDI network have some limitations. First, 360 
participants are not representative of all PWIDs. They are probably more 361 
representative of those who frequent harm reduction programs, where approximately 362 
90% of participants were recruited. Moreover, participants who returned differ slightly 363 
from those with a single visit 13. Participants who returned may have more at risk 364 
behaviours, and this could have overestimated the association with sex work. 365 
Second, self reporting of behaviours may involve social desirability and recall biases 366 
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that may lead to over-reporting of protective behaviours, like condom use, and 367 
underreporting of high risk behaviours, like syringe-sharing, possibly reducing the 368 
strength of the observed associations with HIV incidence.  369 
In conclusion, further studies are needed to understand whether the independent 370 
association between HIV incidence and sex work is related to sexual transmission or 371 
other vulnerability factors, which may include mental illness, poverty and social 372 
exclusion, but increased risk due to sexual transmission cannot be excluded. 373 
374 
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FIGURE HEADINGS 
 
Figure 1: Cumulative hazard of HIV seroconversion and HIV incidence according to 
baseline sexual activity, 2004-2014. Incidence rate calculation based on the sexual 
activity status reported at the second visit (baseline), i.e. exposure during the first time 
interval in the Cox proportional hazard model; Sexual activity is missing for 5 
participants; Sexually active who did not report sex work; py: person-years. 
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Table 1: Baseline1 characteristics and behaviours of participants, 2004-2014 
1
 Baseline characteristics based on information reported at the second visit, i.e. exposure during 
the first time interval in the Cox proportional hazard model. 
2
 Sex is missing for 3 participants 
3
 In the last month 
4
 Sexually active who did not report sex work 
 
Characteristics and behaviours 
n (%) 
Men 
(n=1 147) 
Women (n=378) Total (n=1 528)
2
 
Number of visits, median (min-max) 3 (2-18) 3 (2-14) 3 (2-18) 
Age, mean ± SD 37.8 ± 10.1 32.9 ± 9.5 36.6 ± 10.1 
Age (< 25 years) 113 (9.9) 88 (23.3) 201 (13.2) 
High school completed 563 (49.4) 203 (54.0) 769 (50.7) 
Urban recruitment region 1 027 (89.5) 322 (85.2) 1 352 (88.5) 
Homelessness 506 (44.2) 134 (35.6) 640 (42.0) 
History of incarceration 168 (14.7) 31 (8.2) 200 (13.1) 
Cocaine as the most often injected drug 608 (53.3) 173 (46.0) 783 (51.6) 
Injection with a needle/syringe used by 
someone else 
234 (20.6) 110 (29.4) 344 (22.8) 
Daily injection
3
 405 (35.4) 145 (38.5) 550 (36.1) 
Injection with strangers 402 (35.1) 134 (35.6) 536 (35.2) 
Time since first injection (≥ 6 years) 873 (76.2) 249 (66.4) 1 125 (73.9) 
Sexual activity    
 No sex work
4
 709 (61.9) 181 (48.3) 891 (58.5) 
 Sex work 76 (6.6) 151 (40.3) 229 (15.0) 
 Sexually inactive 360 (31.4) 43 (11.5) 403 (26.5) 
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Table 2: Multivariate analysis1 of the associations between HIV incidence and 
sexual activity, 2004-2014 
 Crude 
HR 
95% CI
2
 AHR 95% CI
2
 
     
Model without effect modification 
    
Socio-demographic variables 
    
Sex (men vs women) 0.61 [0.37-1.02] 0.83 [0.45-1.51] 
Injection behaviours 
    
Injection with a needle/syringe used 
by someone else 
3.04 [1.87-4.93] 2.84 [1.73-4.66] 
Sexual activity 
    
No sex work
3
 1.00  1.00  
Sex work  2.81 [1.55-5.10] 2.19 [1.13-4.25] 
Sexually inactive  1.48 [0.84-2.60] 1.62 [0.92-2.88] 
Model with effect modification by sex
4
  
   
Injection behaviours 
    
Injection with a needle/syringe used 
by someone else 
3.04 [1.87-4.93] 2.91 [1.77-4.77] 
Sexual activity 
    
No sex work 1.00  1.00  
Sex work, women 3.50 [1.26-9.72] 3.31 [1.19-9.21] 
Sexually inactive, women 2.40 [0.57-10.04] 2.86 [0.67-12.01] 
Sex work, men 1.87 [0.64-5.41] 1.64 [0.56-4.77] 
Sexually inactive, men 1.37 [0.74-2.53] 1.47 [0.80-2.73] 
 
1
 Cox proportional hazard regression model; analysis performed using n=1 362 participants, 
excluding those with missing values for any of the independent variables 
2
 95 % confidence intervals 
3
 Sexually active who did not report sex work 
4
 p-value=0.5729 for effect modification, Wald chi-square test 
HR: hazard ratio; AHR: adjusted hazard ratio 
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Table 3: Characteristics and, injection and sex behaviours according to reported sexual 
activity in men1, 2004-2014 
Characteristics and behaviours 
n (%) 
No sex 
work
2
 
(n=656) 
Sex work 
(n=51) 
Sexually 
inactive 
(n=438) 
p-value 
Age, mean ± SD 38.3 ± 10.1 35.6 ± 10.0 42.4 ± 9.7 0.0001 
Age (25 years) 56 (8.5) 6 (11.8) 16 (3.7) 0.0030 
Urban recruitment region  582 (88.7) 47 (92.2) 397 (90.6) 0.4936 
Homelessness  263 (40.2) 30 (60.0) 175 (40.1) 0.0200 
History of incarceration  87 (13.3) 14 (28.0) 59 (13.5) 0.0142 
Drugs used by injection      
 Cocaine 518 (79.1) 44 (86.3) 328 (75.1) 0.0975 
 Heroine 206 (31.5) 19 (37.3) 110 (25.2) 0.0366 
 Dilaudid® (prescribed or not) 296 (45.2) 27 (52.9) 207 (47.6) 0.4707 
Cocaine as the most often injected drug  325 (49.9) 34 (68.0) 224 (52.0) 0.0450 
Non-injected drugs      
 Crack/freebase 420 (64.0) 43 (84.3) 255 (58.2) 0.0007 
 Amphetamines 241 (36.7) 28 (54.9) 102 (23.3) 0.0001 
 Methamphetamine 41 (6.3) 5 (9.8) 18 (4.1) 0.1302 
 Ecstasy 127 (19.4) 11 (21.6) 29 (6.6) 0.0001 
 Dilaudid® (prescribed or not) 163 (24.9) 12 (23.5) 74 (17.0) 0.0083 
Daily injection 
3
 190 (29.1) 17 (34.7) 184 (42.2) 0.0001 
Time since first injection (≥ 6 years) 542 (82.9) 44 (86.3) 371 (84.9) 0.5975 
Injection with strangers  178 (27.3) 24 (47.1) 110 (25.2) 0.0042 
Always injected alone  188 (28.8) 13 (25.2) 185 (42.4) 0.0001 
Injection in public places  368 (56.2) 35 (68.6) 248 (56.6) 0.2219 
Injection with a needle/syringe used by 
someone else  
119 (18.3) 12 (23.5) 62 (14.3) 0.0960 
Injection with needles/syringes used by 
someone else obtained mainly from 
strangers  
20 (3.1) 3 (6.0) 28 (6.5) 0.0291 
Number of female sex partners      
 0 32 (4.9) 21 (41.2) 438 (100) - 
 1 363 (55.3) 8 (15.7) 0 
 2-5 224 (34.2) 15 (29.4) 0 
 6-20 33 (5.0) 5 (9.8) 0 
 21 4 (0.6) 2 (3.9) 0 
Number of male sex partners      
 0 607 (92.5) 11 (21.6) 438 (100) - 
 1 30 (4.6) 8 (15.7) 0 
 2-5 14 (2.1) 11 (21.6) 0 
 6-20 4 (0.6) 7 (13.7) 0 
 21 1 (0.2) 14 (27.5) 0 
Condom use      
    Consistent use for vaginal or anal sex 207 (32.2) 8 (17.0) - - 
    Inconsistent use for vaginal or anal sex 403 (62.7) 20 (42.6) - 
    Oral sex only 33 (5.1) 19 (40.4) - 
Positivity for HCV antibodies  460 (70.1) 45 (88.2) 340 (77.6) 0.0012 
1
 Analyses performed using the last visit for non-seroconverters and the visit when HIV infection was first 
detected for seroconverters 
2
 Sexually active who did not report sex work 
3
 In the last month 
NS : non-significant
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Table 4: Characteristics and, injection and sex behaviours according to reported 
sexual activity in women1, 2004-2014 
Characteristics and behaviours 
n (%) 
No sex 
work
2
 
(n=198) 
Sex work 
(n=129) 
Sexually 
inactive 
(n=46) 
p-value 
Age, mean ± SD 33.5 ± 10.0 34.4 ± 8.6 40.5 ± 10.7 0.0001 
Age ( 25 years) 46 (23.2) 15 (11.6) 3 (6.5) 0.0031 
Urban recruitment region 168 (84.9) 106 (82.2) 44 (95.7) 0.0838 
Homelessness 59 (30.0) 53 (41.4) 11 (23.9) 0.0365 
History of incarceration 11 (5.6) 18 (14.1) 1 (2.2) 0.0068 
Drugs used by injection     
 Cocaine 132 (66.7) 112 (87.5) 25 (54.4) 0.0001 
 Heroine 75 (37.9) 49 (38.3) 10 (21.7) 0.0977 
 Dilaudid® (prescribed or not) 98 (49.8) 66 (51.6) 21 (46.7) 0.8479 
Cocaine as the most often injected drug 80 (40.8) 71 (55.5) 15 (33.3) 0.0085 
Non-injected drugs     
 Crack/freebase 113 (57.1) 92 (71.3) 23 (50.0) 0.0091 
 Amphetamines 64 (32.3) 51 (39.5) 14 (30.4) 0.3337 
 Methamphetamine 8 (4.0) 3 (2.3) 3 (6.5) 0.4171 
 Ecstasy 29 (14.7) 29 (22.5) 4 (8.7) 0.0540 
 Dilaudid® (prescribed or not) 31 (15.7) 30 (23.6) 6 (13.3) 0.1289 
Daily injection
3
 76 (38.8) 55 (42.6) 15 (32.6) 0.4756 
Time since first injection (≥ 6 years) 144 (72.7) 109 (84.5) 39 (84.8) 0.0216 
Injection with strangers 51 (25.9) 49 (38.6) 3 (6.5) 0.0001 
Always injected alone 38 (19.3) 23 (18.1) 18 (39.1) 0.0069 
Injection in public places 98 (49.5) 74 (57.8) 18 (39.1) 0.0762 
Injection with a needle/syringe used by 
someone else 
57 (28.9) 44 (34.9) 3 (6.5) 0.0011 
Injection with needles/syringes used by 
someone else obtained mainly from 
strangers 
6 (3.1) 11 (8.8) 0 (0.0) 0.0166 
Number of female sex partners     
 0 169 (85.4) 105 (82.0) 46 (100) - 
 1 20 (10.1) 11 (8.6) - 
 2-5 9 (4.6) 8 (6.3) - 
 6-20 0 (0.0) 4 (3.1) - 
 21 0 (0.0) 0 (0.0) - 
Number of male sex partners     
 0 11 (5.6) 0 (0.0) 46 (100) - 
  1 136 (69.0) 4 (3.1) - 
 2-5 44 (22.3) 29 (22.5) - 
 6-20 5 (2.5) 34 (26.4) - 
 21 1 (0.5) 62 (48.1) - 
Condom use     
    Consistent use for vaginal or anal sex 26 (13.3) 42 (32.8) -  
    Inconsistent use for vaginal or anal sex 164 (84.1) 78 (60.9) - 
    Oral sex only 5 (2.6) 8 (6.3) - 
Positivity for HCV antibodies 139 (70.2) 107 (83.0) 32 (69.6) 0.0252 
1
 Analyses performed using the last visit for non-seroconverters and the visit when HIV infection 
was first detected for seroconverters 
2
 Sexually active who did not report sex work; 
3
 In the last month 
NS : non-significant 
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